Source – https://www.drugtargetreview.com/ A study has used artificial intelligence to reveal adeno-associated virus (AAV) capsid variants for use in gene therapies. A new study has demonstrated the use of artificial intelligence (AI) to generate a diversity of adeno-associated virus (AAV) capsids towards identifying functional variants capable of evading the immune system, a factor that is critical to Read More